ContractClinical Trial Agreement • September 1st, 2022
Contract Type FiledSeptember 1st, 2022CLINICAL TRIAL AGREEMENT This Clinical Trial Agreement (“Agreement”) is executed as of the of the last signature and effective as of the date of publication in the Contracts Register, a public administration information system in which contracts concluded by entities specified in Act No. 340/2015 Coll., as amended, are published (“Effective Date”) by and among: Labcorp Drug Development Inc., 206 Carnegie Center,Princeton, NJ 08540, USA, Tax ID No.: 22-3265977(hereinafter referred to as “Labcorp”); and Fakultní nemocnice Hradec Králové, Sokolská 581, 500 05 Hradec Králové – Nový Hradec Králové, Czech Republic, represented by prof. MUDr. Vladimírem Paličkou, CSc., dr. h. c., director, Tax ID Nr. CZ00179906, (hereinafter referred to as “Institution”); and workplace: Oncology and Radiotherapy Clinic, Fakultní nemocnice Hradec Králové, Sokolská 581, 500 05 Hradec Králové (hereinafter referred to as “Investigator”) Whereas, Labcorp, Institution and Investigator are hereinafter referred to in